Option Care(OPCH)

Search documents
Option Care Health to Announce Third Quarter 2024 Financial Results and Host Conference Call
GlobeNewswire News Room· 2024-10-02 20:05
Company Overview - Option Care Health Inc. is the nation's largest independent provider of home and alternate site infusion services, employing over 7,500 team members, including more than 4,500 clinicians [3] Upcoming Financial Results - The company will release its third quarter results for the period ended September 30, 2024, on October 30, 2024, before the market opens [1] - A conference call to review the results will be hosted by the management team at 8:30 a.m. E.T. on the same day [1] Conference Call Details - Participants can pre-register for the conference call via a provided link and access it through a live audio webcast [2] - A replay of the call will be available shortly after its completion and will remain accessible for approximately 90 days [2]
OPCH vs. ASTH: Which Stock Is the Better Value Option?
ZACKS· 2024-08-01 16:41
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Option Care (OPCH) and Astrana Health, Inc. (ASTH) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look. The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates and es ...
Wall Street Analysts Predict a 31.8% Upside in Option Care (OPCH): Here's What You Should Know
ZACKS· 2024-08-01 14:55
Shares of Option Care (OPCH) have gained 10.1% over the past four weeks to close the last trading session at $29.69, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $39.13 indicates a potential upside of 31.8%. The mean estimate comprises eight short-term price targets with a standard deviation of $2.64. While the lowest estimate of $36 indicates a 21.3% increase from the curren ...
Should Value Investors Buy Option Care Health (OPCH) Stock?
ZACKS· 2024-08-01 14:46
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies. Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use fundamental analysis and traditional valuation metrics to find stocks that they ...
Option Care(OPCH) - 2024 Q2 - Quarterly Report
2024-07-31 20:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 05-0489664 (State of incorporatio ...
Option Care(OPCH) - 2024 Q2 - Earnings Call Transcript
2024-07-31 18:21
Option Care Health, Inc. (NASDAQ:OPCH) Q2 2024 Earnings Conference Call July 31, 2024 8:30 AM ET Company Participants Nicole Maggio - Senior Vice President of Finance John Rademacher - President & CEO Mike Shapiro - CFO Conference Call Participants Lisa Gill - JPMorgan Constantine Davides - Citizens JMP Matt Larew - William Blair David MacDonald - Truist Securities Pito Chickering - Deutsche Bank Brian Tanquilut - Jefferies Joanna Gajuk - Bank of America Michael Petusky - Barrington Research Operator Good d ...
Option Care (OPCH) Q2 Earnings and Revenues Top Estimates
ZACKS· 2024-07-31 13:21
What's Next for Option Care? Ahead of this earnings release, the estimate revisions trend for Option Care: mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. This company is expected to post quar ...
Option Care Health Announces Financial Results for The Second Quarter Ended June 30, 2024
GlobeNewswire News Room· 2024-07-31 11:00
BANNOCKBURN, Ill., July 31, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Results and Highlights Note that the second quarter of 2023 net income and cash flow from operations includes $62.8 million related to the termination payment received on behalf of A ...
Option Care(OPCH) - 2024 Q2 - Quarterly Results
2024-07-31 10:59
BANNOCKBURN, IL., July 31, 2024 - Option Care Health, Inc. (the "Company" or "Option Care Health") (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2024. Note that the second quarter of 2023 net income and cash flow from operations includes $62.8 million related to the termination payment received on behalf of Amedisys, net of merger-related expenses and taxes. Conference Call OPTIO ...
Option Care Health to Announce Second Quarter 2024 Financial Results and Host Conference Call
GlobeNewswire News Room· 2024-07-08 20:05
Conference Call Details About Option Care Health For Investor Inquiries: BANNOCKBURN, Ill., July 08, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its second quarter ended June 30, 2024 on Wednesday, July 31, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results ...